½ÃÀ庸°í¼­
»óǰÄÚµå
1326584

¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå Á¶»ç ¹× ¿¹Ãø, Àç·á À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, è¹ö À¯Çüº°, Å©±âº°, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Pharmaceutical Cartridges Market Size study & Forecast, by Material Type by Application, by Chamber Type, by Size,by Therapeutic Area, by End Use and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀǾàǰ īƮ¸®Áö ½ÃÀåÀº 2022³â ¾à 13¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 8.5% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀǾàǰ īƮ¸®Áö´Â Á¦¾à »ê¾÷¿¡¼­ ÀǾàǰÀ» º¸°üÇÏ°í ¹è¼ÛÇÏ´Â µ¥ »ç¿ëµÇ´Â Ư¼ö ¿ë±âÀÔ´Ï´Ù. Á¤È®ÇÑ ¾çÀÇ ¾à¹°À» ´ãÀ» ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î ¾à¹°À» Åõ¿©ÇÏ´Â ¾ÈÀüÇÏ°í Æí¸®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀǾàǰ īƮ¸®Áö´Â ƯÈ÷ ÁÖ»çÁ¦ÀÇ ¾ÈÀüÇϰí È¿°úÀûÀÎ Àü´Þ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀǾàǰÀÇ º¸°ü, Á¤È®ÇÑ Åõ¿© ¹× °ü¸®µÈ Åõ¿©¸¦ À§ÇÑ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼ö´ÜÀ» Á¦°øÇÏ¿© ÀǾàǰÀÇ Àü¹ÝÀûÀΠǰÁú°ú È¿À²¼º¿¡ ±â¿©ÇÕ´Ï´Ù. ÀǾàǰ īƮ¸®Áö ½ÃÀåÀÇ ¼ºÀå ¹è°æ¿¡´Â ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¾à¹° Àü´Þ ÀåÄ¡ÀÇ ±â¼ú ¹ßÀüÀÌ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

°üÀý¿°, ´ç´¢º´ µî ´Ù¾çÇÑ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ÀǾàǰ īƮ¸®Áö äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀǾàǰ īƮ¸®Áö´Â Á¤È®ÇÑ ¿ë·®À» °ø±ÞÇϵµ·Ï ¼³°èµÇ¾î Åõ¾à ¿À·ùÀÇ °¡´É¼ºÀ» ÁÙ¿©ÁÝ´Ï´Ù. ÀÌ´Â ´ç´¢º´, °üÀý¿° ¹× ±âŸ ¸¸¼º Áúȯ°ú °°ÀÌ º¹¾à ¼øÀÀµµ°¡ Áß¿äÇÑ Áúȯ¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)¿¡ µû¸£¸é 2020³â ¹Ì±¹¿¡¼­ ¾à 6,300¸¸ ¸íÀÌ °üÀý¿° Áø´ÜÀ» ¹Þ¾ÒÀ¸¸ç, 2045³â¿¡´Â 7,800¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ±¹Á¦´ç´¢º´¿¬¸ÍÀÌ ¹ßÇ¥ÇÑ 2021³â ´ç´¢º´ ¾ÆÆ²¶ó½º¿¡ µû¸£¸é, 2021³â¿¡´Â ¼¼°èÀûÀ¸·Î ¾à 5¾ï 3,660¸¸ ¸íÀÇ ´ç´¢º´ ȯÀÚ°¡ ¹ß»ýÇϸç, 2045³â¿¡´Â 7¾ï 8,370¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ±¹³» ÀǾàǰ Á¦Á¶¿¡ ´ëÇÑ Á¤ºÎÀÇ ¼ºÇâÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª À§Á¶Ç° Áõ°¡¿Í À¯¸® Ç¥¸é°ú °ü·ÃµÈ ¹®Á¦´Â 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ ¿ìÀ§, ´Ù¾çÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¦¾à ÀåÄ¡ °³¹ß Ȱµ¿ Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ´ç´¢º´ Àα¸ Áõ°¡, Á¦Ç° °³¹ß Ȱµ¿ Áõ°¡, ¿¬±¸ °³¹ß Ȱµ¿ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ, ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ȯ°æ°ú ½ÃÀå »óȲ¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°è ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå ¿ªÇÐ

  • ÀǾàǰ īƮ¸®Áö ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼ºÁúȯ Áõ°¡
      • ¾à¹°Àü´Þ µð¹ÙÀ̽º ±â¼ú Áøº¸ Áõ°¡
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
      • À§Á¶Ç° Áõ°¡
      • À¯¸® Ç¥¸é¿¡ °üÇÑ °úÁ¦
    • ½ÃÀå ±âȸ
      • ÇコÄɾî ÁöÃâ Áõ°¡
      • ±¹³» ÀǾàǰ Á¦Á¶¿¡ ´ëÇÑ Á¤ºÎ °æ»ç Áõ°¡

Á¦4Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five Forces ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : Àç·á À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : Àç·á À¯Çüº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : Àç·á À¯Çüº° ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
  • ÀǾàǰ īƮ¸®Áö ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • À¯¸®Á¦ īƮ¸®Áö
    • ÇÃ¶ó½ºÆ½ īƮ¸®Áö
    • °í¹« īƮ¸®Áö

Á¦6Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : ¿ëµµº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø2020-2030³â
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Ä¡°ú ¸¶Ãë
    • ÆæÇü ÁÖ»ç±â
    • ÀÚµ¿ ÁÖ»ç±â
    • ¿þ¾î·¯ºí ÁÖ»ç±â

Á¦7Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : è¹ö À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : è¹ö À¯Çüº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : è¹ö À¯Çüº° ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
  • ÀǾàǰ īƮ¸®Áö ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • µà¾ó è¹ö
    • ´ë¿ë·®

Á¦8Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : »çÀÌÁ

  • ½ÃÀå ÇöȲ
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : »çÀÌÁ, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : »çÀÌÁ Ã߻ꡤ¿¹Ãø : 2020-2030³â
  • ÀǾàǰ īƮ¸®Áö ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • 0.5 ml
    • 1.8ml
    • 2 ml-2.5ml
    • 3ml
    • 5ml
    • 10 mlÀÌ»ó

Á¦9Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : Ä¡·á ºÐ¾ßº°

  • ½ÃÀå ÇöȲ
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : Ä¡·á ºÐ¾ßº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : Ä¡·á ºÐ¾ßº° ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
  • ÀǾàǰ īƮ¸®Áö ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¾È°ú
    • È£Èí±â
    • ½Å°æ
    • Á¾¾çÇÐ
    • ¸é¿ªÇÐ
    • ¼øÈ¯±â ³»°ú
    • ´ç´¢º´
    • ±âŸ

Á¦10Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
  • ÀǾàǰ īƮ¸®Áö ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ÀǾàǰ
    • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö
    • ¿¬±¸±â°ü
    • ±âŸ

Á¦11Àå ÀǾàǰ īƮ¸®Áö ¼¼°è ½ÃÀå, Áö¿ª ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ÀǾàǰ īƮ¸®Áö ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´ ÀǾàǰ īƮ¸®Áö ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÀǾàǰ īƮ¸®Áö ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ÀǾàǰ īƮ¸®Áö ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Stevanato Group
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Nipro Corporation
    • Gerresheimer AG
    • West Pharmaceutical Services, Inc.
    • Schott AG
    • Transcoject GmbH
    • Shandong Medicinal Glass Co., Ltd.
    • Datwyler Holding Inc.
    • AptarGroup, Inc.
    • Sonata Rubber Pvt. Ltd.

Á¦13Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
LSH 23.09.18

Global Pharmaceutical Cartridges Market is valued at approximately USD 1.30 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2023-2030. Pharmaceutical cartridges are specialized containers used in the pharmaceutical industry to store and deliver medications. They are designed to hold a precise volume of medication and provide a secure and convenient way to administer drugs. Pharmaceutical cartridges play a vital role in the safe and effective delivery of medications, particularly for injectable drugs. They provide a reliable means of storage, accurate dosing, and controlled administration, contributing to the overall quality and efficiency of pharmaceutical products. The Pharmaceutical Cartridges market is expanding because of factors such as the rising prevalence of chronic conditions and growing technological advancements in drug delivery devices.

The rising prevalence of various chronic conditions such as arthritis and diabetes is driving the adoption of pharmaceutical cartridges. Pharmaceutical cartridges are designed to deliver accurate doses, reducing the potential for dosing errors. This is especially crucial in conditions where medication adherence is critical, such as diabetes, arthritis, and other chronic conditions. According to the Centers for Disease Control and Prevention, in the year 2020, there were around 63 million people in the US diagnosed with arthritis which is expected to reach 78 million by the year 2045. Along with these, International Diabetes Federation's Diabetes Atlas for 2021, reports that there were around 536,600,000 cases of diabetes worldwide in 2021, and that number is expected to rise to 783,700,000 by the year 2045. In addition, rising healthcare expenditure and growing government inclination toward domestic drug manufacturing are creating a lucrative opportunity for the market. However, the growing number of counterfeit products and challenges associated with glass surfaces stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pharmaceutical Cartridges Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players and increasing prevalence of various chronic conditions, rising drug device development activities. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising diabetic populations, an increase in the number of product development activities, rising number of research and development activities in the region.

Major market player included in this report are:

  • Stevanato Group
  • Nipro Corporation
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Transcoject GmbH
  • Shandong Medicinal Glass Co., Ltd.
  • Datwyler Holding Inc.
  • AptarGroup, Inc.
  • Sonata Rubber Pvt Ltd.

Recent Developments in the Market:

  • In March 2023, PCI Pharma Services, a biopharmaceutical contract manufacturing partner, started a USD 50 million expansion project at its Illinois sterile injectables facility. In order to improve the facility's capacity to accommodate injectable drug-device combo solutions, the project comprises the construction of a new facility..

Global Pharmaceutical Cartridges Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Material Type, Application, Chamber Type, Size, Therapeutic Area, End-use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Material Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Material Type:

  • Glass Cartridges
  • Plastic Cartridges
  • Rubber Cartridges

By Application:

  • Dental Anesthesia
  • Pen Injectors
  • Autoinjectors
  • Wearable Injectors

By Chamber Type:

  • Dual Chamber
  • Large Volume

By Size:

  • 0.5 ml
  • 1.8 ml
  • 2ml to 2.5 ml
  • 3 ml
  • 5 ml
  • More than 10 ml

By Therapeutic Area:

  • Ophthalmology
  • Respiratory
  • Neurology
  • Oncology
  • Immunology
  • Cardiology
  • Diabetes
  • Others

By End Use:

  • Pharmaceuticals
  • Biotechnology
  • Research Organizations
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Pharmaceutical Cartridges Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Pharmaceutical Cartridges Market, by Material Type, 2020-2030 (USD Billion)
    • 1.2.3. Pharmaceutical Cartridges Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Pharmaceutical Cartridges Market, by Chamber Type, 2020-2030 (USD Billion)
    • 1.2.5. Pharmaceutical Cartridges Market, by Size, 2020-2030 (USD Billion)
    • 1.2.6. Pharmaceutical Cartridges Market, by Therapeutic Area, 2020-2030 (USD Billion)
    • 1.2.7. Pharmaceutical Cartridges Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pharmaceutical Cartridges Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Cartridges Market Dynamics

  • 3.1. Pharmaceutical Cartridges Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of chronic conditions
      • 3.1.1.2. Growing technological advancements in drug delivery devices
    • 3.1.2. Market Challenges
      • 3.1.2.1. Growing number of counterfeit products
      • 3.1.2.2. Challenges associated with glass surface
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising Healthcare expenditure
      • 3.1.3.2. Growing government inclination toward domestic drug manufacturing

Chapter 4. Global Pharmaceutical Cartridges Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Pharmaceutical Cartridges Market, by Material Type

  • 5.1. Market Snapshot
  • 5.2. Global Pharmaceutical Cartridges Market by Material Type, Performance - Potential Analysis
  • 5.3. Global Pharmaceutical Cartridges Market Estimates & Forecasts by Material Type 2020-2030 (USD Billion)
  • 5.4. Pharmaceutical Cartridges Market, Sub Segment Analysis
    • 5.4.1. Glass Cartridges
    • 5.4.2. Plastic Cartridges
    • 5.4.3. Rubber Cartridges

Chapter 6. Global Pharmaceutical Cartridges Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Pharmaceutical Cartridges Market by Application, Performance - Potential Analysis
  • 6.3. Global Pharmaceutical Cartridges Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Pharmaceutical Cartridges Market, Sub Segment Analysis
    • 6.4.1. Dental Anesthesia
    • 6.4.2. Pen Injectors
    • 6.4.3. Autoinjectors
    • 6.4.4. Wearable Injectors

Chapter 7. Global Pharmaceutical Cartridges Market, by Chamber Type

  • 7.1. Market Snapshot
  • 7.2. Global Pharmaceutical Cartridges Market by Chamber Type, Performance - Potential Analysis
  • 7.3. Global Pharmaceutical Cartridges Market Estimates & Forecasts by Chamber Type 2020-2030 (USD Billion)
  • 7.4. Pharmaceutical Cartridges Market, Sub Segment Analysis
    • 7.4.1. Dual Chamber
    • 7.4.2. Large Volume

Chapter 8. Global Pharmaceutical Cartridges Market, by Size

  • 8.1. Market Snapshot
  • 8.2. Global Pharmaceutical Cartridges Market by Size, Performance - Potential Analysis
  • 8.3. Global Pharmaceutical Cartridges Market Estimates & Forecasts by Size 2020-2030 (USD Billion)
  • 8.4. Pharmaceutical Cartridges Market, Sub Segment Analysis
    • 8.4.1. 0.5 ml
    • 8.4.2. 1.8 ml
    • 8.4.3. 2ml to 2.5 ml
    • 8.4.4. 3 ml
    • 8.4.5. 5 ml
    • 8.4.6. More than 10 ml

Chapter 9. Global Pharmaceutical Cartridges Market, by Therapeutic Area

  • 9.1. Market Snapshot
  • 9.2. Global Pharmaceutical Cartridges Market by Therapeutic Area, Performance - Potential Analysis
  • 9.3. Global Pharmaceutical Cartridges Market Estimates & Forecasts by Therapeutic Area 2020-2030 (USD Billion)
  • 9.4. Pharmaceutical Cartridges Market, Sub Segment Analysis
    • 9.4.1. Ophthalmology
    • 9.4.2. Respiratory
    • 9.4.3. Neurology
    • 9.4.4. Oncology
    • 9.4.5. Immunology
    • 9.4.6. Cardiology
    • 9.4.7. Diabetes
    • 9.4.8. Others

Chapter 10. Global Pharmaceutical Cartridges Market, by End-Use

  • 10.1. Market Snapshot
  • 10.2. Global Pharmaceutical Cartridges Market by End-Use, Performance - Potential Analysis
  • 10.3. Global Pharmaceutical Cartridges Market Estimates & Forecasts by End-Use 2020-2030 (USD Billion)
  • 10.4. Pharmaceutical Cartridges Market, Sub Segment Analysis
    • 10.4.1. Pharmaceuticals
    • 10.4.2. Biotechnology
    • 10.4.3. Research Organizations
    • 10.4.4. Others

Chapter 11. Global Pharmaceutical Cartridges Market, Regional Analysis

  • 11.1. Top Leading Countries
  • 11.2. Top Emerging Countries
  • 11.3. Pharmaceutical Cartridges Market, Regional Market Snapshot
  • 11.4. North America Pharmaceutical Cartridges Market
    • 11.4.1. U.S. Pharmaceutical Cartridges Market
      • 11.4.1.1. Material Type breakdown estimates & forecasts, 2020-2030
      • 11.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 11.4.1.3. Chamber Type breakdown estimates & forecasts, 2020-2030
      • 11.4.1.4. Size breakdown estimates & forecasts, 2020-2030
      • 11.4.1.5. Therapeutic Area breakdown estimates & forecasts, 2020-2030
      • 11.4.1.6. End-Use breakdown estimates & forecasts, 2020-2030
    • 11.4.2. Canada Pharmaceutical Cartridges Market
  • 11.5. Europe Pharmaceutical Cartridges Market Snapshot
    • 11.5.1. U.K. Pharmaceutical Cartridges Market
    • 11.5.2. Germany Pharmaceutical Cartridges Market
    • 11.5.3. France Pharmaceutical Cartridges Market
    • 11.5.4. Spain Pharmaceutical Cartridges Market
    • 11.5.5. Italy Pharmaceutical Cartridges Market
    • 11.5.6. Rest of Europe Pharmaceutical Cartridges Market
  • 11.6. Asia-Pacific Pharmaceutical Cartridges Market Snapshot
    • 11.6.1. China Pharmaceutical Cartridges Market
    • 11.6.2. India Pharmaceutical Cartridges Market
    • 11.6.3. Japan Pharmaceutical Cartridges Market
    • 11.6.4. Australia Pharmaceutical Cartridges Market
    • 11.6.5. South Korea Pharmaceutical Cartridges Market
    • 11.6.6. Rest of Asia Pacific Pharmaceutical Cartridges Market
  • 11.7. Latin America Pharmaceutical Cartridges Market Snapshot
    • 11.7.1. Brazil Pharmaceutical Cartridges Market
    • 11.7.2. Mexico Pharmaceutical Cartridges Market
  • 11.8. Middle East & Africa Pharmaceutical Cartridges Market
    • 11.8.1. Saudi Arabia Pharmaceutical Cartridges Market
    • 11.8.2. South Africa Pharmaceutical Cartridges Market
    • 11.8.3. Rest of Middle East & Africa Pharmaceutical Cartridges Market

Chapter 12. Competitive Intelligence

  • 12.1. Key Company SWOT Analysis
    • 12.1.1. Company 1
    • 12.1.2. Company 2
    • 12.1.3. Company 3
  • 12.2. Top Market Strategies
  • 12.3. Company Profiles
    • 12.3.1. Stevanato Group
      • 12.3.1.1. Key Information
      • 12.3.1.2. Overview
      • 12.3.1.3. Financial (Subject to Data Availability)
      • 12.3.1.4. Product Summary
      • 12.3.1.5. Recent Developments
    • 12.3.2. Nipro Corporation
    • 12.3.3. Gerresheimer AG
    • 12.3.4. West Pharmaceutical Services, Inc.
    • 12.3.5. Schott AG
    • 12.3.6. Transcoject GmbH
    • 12.3.7. Shandong Medicinal Glass Co., Ltd.
    • 12.3.8. Datwyler Holding Inc.
    • 12.3.9. AptarGroup, Inc.
    • 12.3.10. Sonata Rubber Pvt. Ltd.

Chapter 13. Research Process

  • 13.1. Research Process
    • 13.1.1. Data Mining
    • 13.1.2. Analysis
    • 13.1.3. Market Estimation
    • 13.1.4. Validation
    • 13.1.5. Publishing
  • 13.2. Research Attributes
  • 13.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦